Related Experiment Video
Updated: Jul 19, 2026

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro
Published on: December 5, 2025
The adipokine visfatin is markedly elevated in obese children
Dominik G Haider1, Gregor Holzer, Georg Schaller
1Department of Clinical Pharmacology, Medical University of Vienna, Austria.
Objective:
The insulin-mimetic adipocytokine visfatin has been linked to adiposity and the metabolic syndrome.
Design:
Cross-sectional study.
Subjects:
Eighty-three nondiabetic obese children and 40 healthy controls.
Measurements:
We analyzed plasma visfatin concentrations to assess whether this adipokine is associated with adiposity.
Results:
Plasma visfatin concentrations were nearly 2-fold higher in obese children (mean, 1.1 ng/mL; 95% CI, 0.2-6.6) than in controls (0.6 ng/mL, 95% CI, 0.6 to 0.6; P < 0.001). No relationship was detectable between visfatin and other subject characteristics, hsCRP or the lipid profile.
Conclusions:
Visfatin may be involved in the development of metabolic derangements in obese children.
More Related Videos
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Hypodermis
Cholesterol: Significance and Regulation
Considering cholesterol and...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

